Kestra Medical Technologies, Ltd. Common Stock (KMTS) Financials
Key financial figures for Kestra Medical Technologies, Ltd. Common Stock (Q1 2027).
Kestra Medical Technologies, Ltd. reported revenue of $31.0 million for Q1 FY2027, up 59.9% from the same period a year earlier. The company posted a net loss of $44.1 million, or -$0.75 per share. Operating margin came to -121.59%, against -149.08% a year earlier. Free cash flow for the period was -$40.6 million. Across the last 5 reported quarters, quarterly revenue has risen from $19.4 million in Q1 FY2026 to $31.0 million in Q1 FY2027. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Kestra Medical Technologies, Ltd. are on the SentiSense financials page.
- Revenue
- $31M
- Net Income
- -$44M
- EPS
- $-0.75
- Total Assets
- $347M
- Operating Cash Flow
- -$32M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q1 FY2027 | $31M | -$44M | -$0.75 | -121.59% | -$41M |
| Q4 FY2026 | $29M | -$39M | -$0.67 | -137.38% | -$28M |
| Q3 FY2026 | $25M | -$34M | -$0.61 | -141.59% | -$28M |
| Q2 FY2026 | $23M | -$33M | -$0.64 | -140.73% | -$26M |
| Q1 FY2026 | $19M | -$26M | -$0.50 | -149.08% | -$34M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $95M | -$132M | -$2.43 | -141.64% | -$117M |
| FY2025 | $60M | -$114M | -$5.13 | -177.85% | -$101M |
| FY2024 | $28M | -$94M | -$2.04 | -305.83% | -$85M |
Frequently asked questions
What was Kestra Medical Technologies, Ltd.'s revenue last quarter?
Kestra Medical Technologies, Ltd. reported revenue of $31.0 million for Q1 FY2027, up 59.9% from the same period a year earlier.
Is Kestra Medical Technologies, Ltd. profitable?
Not in its most recent reported period. Kestra Medical Technologies, Ltd. reported a net loss of $44.1 million for Q1 FY2027, a net margin of -142.35% on revenue.
How has Kestra Medical Technologies, Ltd.'s margin trended?
Operating margin was -121.59% in Q1 FY2027, compared with -149.08% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Kestra Medical Technologies, Ltd. generate?
Kestra Medical Technologies, Ltd. generated free cash flow of -$40.6 million in Q1 FY2027, after capital expenditure.
Full income statement, balance sheet and cash flow for Kestra Medical Technologies, Ltd. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.